MRTLE2 Study vs JNJ_80202135EBF3001
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MRTLE2 Study
Read full descriptionHide full description
This app is an advanced electronic patient diary targeted specifically for epilepsy patients who are having a severe case of epilepsy. This app allows patients to enter data about their seizures, side effects and guides them in providing a very detailed and granular information that helps assessing their condition.
JNJ_80202135EBF3001
Read full descriptionHide full description
The Janssen COA App is intended for use collect patient reported outcomes relating to a clinical trial. Patients must be given accounts by a participating site in order to log in to the app.
Screenshots
Verdict
The clearest difference is iOS requirement: MRTLE2 Study at 13.0 against JNJ_80202135EBF3001's 17.0. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MRTLE2 Study ships an update every 5 weeks, JNJ_80202135EBF3001 monthly. The most recent releases landed on October 8, 2026 and October 17, 2026 respectively.
| Parameter | MRTLE2 Study | JNJ_80202135EBF3001 |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 5 weeks | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPod | iPhone, iPad |
| Requires iOS | 13.0 — better | 17.0 |
| Further details — not scored | ||
| Size | 9 MB | 90 MB |
| Age rating | 17+ | 12+ |
| Developer | Irody Inc. | ERT,INC |
In-app purchases
MRTLE2 Study
No in-app purchases
JNJ_80202135EBF3001
No in-app purchases
